NYSE:HYH Halyard Health (HYH) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free HYH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$56.93▼$57.9150-Day Range N/A52-Week Range$38.22▼$61.52Volume886,271 shsAverage Volume438,537 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Halyard Health alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Halyard Health Stock (NYSE:HYH)Avanos Medical, Inc. operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients' quality of life. The firm's portfolio of product offerings focuses on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> HYH Stock News HeadlinesFebruary 10, 2024 | benzinga.comHALYARD PRINCIPALS LLC's Net WorthFebruary 6, 2024 | bloomberg.comHealth CareApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 1, 2024 | investing.comAvanos Medical Inc (AVNS)November 21, 2023 | news.yahoo.comYahoo News: Latest and Breaking News, Headlines, Live Updates, and MoreMay 21, 2023 | forbes.comWhat Is Concierge Medicine And Is It Worth The Price Tag?January 5, 2023 | thestreet.comHalyard Health (HYH) Stock Falls on '60 Minutes' AllegationsJuly 16, 2022 | thestreet.com3 High-Yield, Low-Risk Dividend Stocks for Extreme SafetyApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.October 26, 2021 | finance.yahoo.comHalyard Health Announces New Drainage System, Stock DownSee More Headlines Receive HYH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Halyard Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/01/2017Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical Appliances & Supplies Sub-IndustryN/A Current SymbolNYSE:HYH CUSIPN/A CIK1606498 Webwww.halyardhealth.com Phone(844) 428-2667FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesJoseph F. WoodyChief Executive Officer & Executive DirectorMichael C. GreinerChief Financial Officer & Senior Vice PresidentLee BurnesSenior VP-Global Research & DevelopmentMichelle ScharfenbergSenior VP, Chief Ethics & Compliance OfficerRhonda D. GibbyChief Human Resources Officer & Senior VPKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAlpha Tau MedicalNASDAQ:DRTSWView All Competitors HYH Stock Analysis - Frequently Asked Questions How were Halyard Health's earnings last quarter? Halyard Health, Inc. (NYSE:HYH) issued its quarterly earnings results on Wednesday, November, 1st. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.13. The medical instruments supplier earned $401.40 million during the quarter, compared to analyst estimates of $394.54 million. Halyard Health's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the firm posted $0.48 earnings per share. What other stocks do shareholders of Halyard Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Halyard Health investors own include Kimberly-Clark (KMB), Allergan (AGN), Cisco Systems (CSCO), General Electric (GE), Kinder Morgan (KMI), Gilead Sciences (GILD), Intel (INTC), Ionis Pharmaceuticals (IONS) and Johnson & Johnson (JNJ). This page (NYSE:HYH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halyard Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.